| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Eric P Moll van Charante | Q56924362 |
| P2093 | author name string | Willem A van Gool | |
| Edo Richard | |||
| Esmé Eggink | |||
| P2860 | cites work | Forecasting the global burden of Alzheimer’s disease | Q22252403 |
| Statins for the prevention of dementia | Q24186591 | ||
| Global prevalence of dementia: a Delphi consensus study | Q24603249 | ||
| Vascular risk factors and dementia: how to move forward? | Q24650263 | ||
| Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease | Q28216782 | ||
| Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial | Q28286628 | ||
| Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study | Q28366850 | ||
| Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment | Q30489448 | ||
| Potential for primary prevention of Alzheimer's disease: an analysis of population-based data | Q30836810 | ||
| Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project | Q33306599 | ||
| The neuropathology of probable Alzheimer disease and mild cognitive impairment | Q33616561 | ||
| Community programs for the prevention of cardiovascular disease: a systematic review | Q33644109 | ||
| Vascular factors and Alzheimer disease | Q33803166 | ||
| Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). | Q33935314 | ||
| Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. | Q33950366 | ||
| Aggregation of vascular risk factors and risk of incident Alzheimer disease | Q33989502 | ||
| Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s | Q34066971 | ||
| The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study | Q44175666 | ||
| The European Dementia Prevention Initiative | Q44655081 | ||
| Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-a randomized clinical trial. | Q45988413 | ||
| High total cholesterol levels in late life associated with a reduced risk of dementia. | Q46505847 | ||
| Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease | Q46745854 | ||
| Education and dementia: a meta-analytic study | Q47205491 | ||
| Physical Activity Interventions in Preventing Cognitive Decline and Alzheimer-Type Dementia: A Systematic Review | Q47285387 | ||
| Mixed brain pathologies account for most dementia cases in community-dwelling older persons | Q48136681 | ||
| Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics. | Q48463721 | ||
| Chronic brain ischemia: the contributions of Otto Binswanger and Alois Alzheimer to the mechanisms of vascular dementia | Q48883454 | ||
| A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. | Q50578805 | ||
| Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study. | Q50798207 | ||
| The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. | Q51183354 | ||
| A population-based study of dementia in 85-year-olds. | Q52038432 | ||
| Lower dementia risk with different classes of antihypertensive medication in older patients. | Q52094859 | ||
| Report of the task force on designing clinical trials in early (predementia) AD. | Q34555301 | ||
| Dietary patterns and risk of dementia: the Three-City cohort study. | Q34584817 | ||
| Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease | Q34662682 | ||
| Role of the neuropathology of Alzheimer disease in dementia in the oldest-old | Q34764490 | ||
| Strategy of prevention: lessons from cardiovascular disease. | Q34782046 | ||
| Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study | Q34866029 | ||
| Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers | Q35170855 | ||
| Functional interaction between APOE4 and LDL receptor isoforms in Alzheimer's disease | Q35447761 | ||
| Exercise, brain, and cognition across the life span | Q35562026 | ||
| Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy | Q35905639 | ||
| The age-dependent relation of blood pressure to cognitive function and dementia | Q36201875 | ||
| Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. | Q36406404 | ||
| Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis | Q36465225 | ||
| Metabolic syndrome and cognitive disorders: is the sum greater than its parts? | Q36838854 | ||
| Brain reserve and the prevention of dementia | Q37125840 | ||
| Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence | Q37197121 | ||
| Effect of infarcts on dementia in the Baltimore longitudinal study of aging | Q37221901 | ||
| Predicting risk of dementia in older adults: The late-life dementia risk index | Q37274596 | ||
| Blood pressure and the risk for dementia: a double edged sword. | Q37343657 | ||
| Methodological issues in primary prevention trials for neurodegenerative dementia | Q37394535 | ||
| Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
| Vascular and psychosocial factors in Alzheimer's disease: epidemiological evidence toward intervention | Q37698034 | ||
| Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin | Q37978026 | ||
| Calcium channel blockers and Alzheimer's disease: potential relevance in treatment strategies of metabolic syndrome | Q37989307 | ||
| Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease | Q38116974 | ||
| Molecular links between Alzheimer's disease and diabetes mellitus | Q38122603 | ||
| 2003-2013: a decade of body mass index, Alzheimer's disease, and dementia | Q38242147 | ||
| Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions | Q38554910 | ||
| Dementia in western Europe: epidemiological evidence and implications for policy making | Q38572254 | ||
| Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial | Q38836227 | ||
| Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI). | Q39582509 | ||
| Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial | Q40266298 | ||
| Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study | Q40297061 | ||
| Brain infarction and the clinical expression of Alzheimer disease. The Nun Study | Q42435324 | ||
| Sick individuals and sick populations | Q43440816 | ||
| Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation | Q43763511 | ||
| The Environment and Disease: Association or Causation? | Q55037638 | ||
| World Wide Fingers will advance dementia prevention | Q58417447 | ||
| Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease | Q60233030 | ||
| 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol | Q63443842 | ||
| Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial | Q64117613 | ||
| Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds | Q64120773 | ||
| Action Plan for Stroke in Europe 2018-2030. | Q64915701 | ||
| Blood pressure-lowering interventions to prevent dementia: a systematic review and meta-analysis | Q89176780 | ||
| Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data | Q89992633 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| P577 | publication date | 2019-06-12 | |
| P1433 | published in | Journal of Clinical Medicine | Q27724774 |
| P1476 | title | A Population Perspective on Prevention of Dementia | |
| P478 | volume | 8 |
Search more.